Back to search

National and Kapodistrian University of Athens

Επίπτωση και παράγοντες κινδύνου των συμβαμάτων που σχετίζονται με τον αναπνευστήρα σε ασθενείς με μηχανική υποστήριξη αναπνοής στη ΜΕΘ

Abstract

dc:description

Objective and practical approaches for the surveillance of Healthcare-Associated Infections (HCAI), which facilitate valid comparisons between services at national and international levels and furthermore improve healthcare quality, are now considered necessary. Monitoring and identifying healthcare-associated events is expected to be automated and electronic-based and in addition, reporting the metrics for these events, is expected to be based on objective clinical criteria rather than on bedside diagnostic approaches, which are often complex and subjective. Ventilator-Associated Events (VAEs) surveillance is a step towards this direction. Recently, the US Centers for Disease Control and Prevention (CDC) expanded the surveillance goals from Ventilator Associated Pneumonia (VAP) to VAEs. Considering that VAEs are a broader entity than VAP and that they are more frequent than VAP, but also given the association of VAEs with adverse outcomes, it is imperative to investigate risk factors in order to develop appropriate preventive strategies. The main purpose of the present study was to estimate the mean incidence of VAEs and to identify possible risk factors for VAEs in adult patients under invasive mechanical ventilation, who were hospitalized in Intensive Care Units (ICUs).The individual objectives of the study were: • To estimate the mean incidence of Ventilator Associated Conditions(VAC), • To estimate the mean incidence of Infection-related Ventilator Associated Complications (IVAC), • To estimate the mean incidence of possible Ventilator-Associated Pneumonia (pVAP), • To estimate the VAE rate per 100 episodes of mechanical ventilation, • To estimate the Standardized Infection Ratio (SIR) for all VAEs and the sub-category of IVAC plus, • To estimate the Standardized Utilization Ratio (SUR) for the ventilator • To estimate of the Device Utilization Ratio for the ventilator, • To estimate the mortality of patients with VAE, • To identify risk factors for VAE, • To identify risk factors for VAC, • To identify risk factors for IVAC plus (the sum of IVAC and pVAP). The study was carried out in 4 ICUs in Attica, from 1/1/2018 to 1/1/2020. The study population consisted of all adult patients who during the surveillance, were under invasive mechanical ventilation in the ICU for ≥4 days. Patients were monitored daily until discharge from the ICU or until death. CDC standard definitions and protocols as published in 2018 were used to diagnose VAEs and monitor patients. VAE definitions are based on a combination of objective criteria, which include deterioration of respiratory function after a period of stabilization or improvement on the ventilator, documentation of infection or inflammation and laboratory confirmation of respiratory infection. Patients should be mechanically ventilated for at least 4 calendar days to meet VAE criteria. The day of initiation of mechanical ventilation is considered day 1, whereas the earliest a VAE can occur, is day 3 of mechanical ventilation (the day on which oxygenation deteriorates). The reference period of stabilization or improvement on the ventilator refers to the first two days, preceding the first day of increase in ventilator settings (increase in the minimum daily value of PEEP-positive end-expiratory pressure or inspired fraction of oxygen-FiO2) and must be characterized of ≥2 calendar days of stabilization or reduction of daily minimum values of PEEP or FiO2. The minimum daily value of PEEP or FiO2 used for VAE monitoring, is the lowest value during a calendar day, if this value was maintained for at least 1 hour. An 1:1 matched “case-control” study was performed. During the surveillance period, 500 patients aged ≥18 years were on invasive mechanical ventilation for ≥4 days, 207 of whom experienced VAE. Among patients with VAE, 163 were successfully matched to 163 “controls” without VAE, on the basis of age (± 5years), sex, Charlson Score (± 2 points), hospital, and duration of mechanical ventilation before the onset of VAE in “cases”. Univariable and multivariable conditional logistic regression and Cox proportional hazard models were used to investigate potentially modifiable risk factors for VAEs. The data were analyzed using the statistical program SPSS (Statistical Package for Social Sciences) v. 24.0. The mean incidence of VAEs per 1000 ventilator days was calculated by dividing the number of VAEs by the total days of mechanical ventilation and multiplying the result by 1000 (days of mechanical ventilation).The VAE rate per 100 episodes of mechanical ventilation was calculated by dividing the number of VAEs by the total number of episodes of mechanical ventilation and multiplying the result by 100 (episodes of mechanical ventilation). The Standardized Infection Ratio (SIR) for all VAEs was calculated by dividing the number of observed VAEs by the number of expected VAEs. Similarly, the SIR for the subcategory of IVAC plus was calculated by dividing the number of observed IVAC plus by the number of expected IVAC plus. A negative binomial logistic regression model is used to perform the VAE SIR calculations. The Standardized Utilization Ratio (SUR) was calculated by dividing the observed number of ventilator days by the expected number of ventilator days. The expected number of ventilator days is calculated using a logistic regression model. The Device Utilization Ratio (DUR) was calculated by dividing the number of ventilator days by the number of patient days. During the study period, there were 500 hospitalized patients under mechanical ventilation for ≥4 days. The sum of patient days was 12,689 and the sum of ventilator days was 10,099. The majority of patients were male (59.4%) with a median age of 61.5 years. The most common underlying diseases were renal failure (26%), diabetes mellitus (18.2%) and chronic lung disease (17.6%). The most common causes of mechanical ventilation were respiratory disorders (20.4%), central nervous system disorders (19.4%), and postoperative care (18.0%). 207 of 500 patients (41.4%) experienced VAE. Overall, 106 VAC (17.5 per 100 episodes of mechanical ventilation and 10.5 per 1000 ventilator days), 65 IVAC (10.8 per 100 episodes of mechanical ventilation and 6.4 per 1000 ventilator days), 36 pVAP (6 per 100 episodes of mechanical ventilation and 3.6 per 1000 ventilator days),101 IVAC plus (16.7 per 100 episodes of mechanical ventilation and 10 per 1000 ventilator days) and 207 VAE overall (34.3 per 100 episodes of mechanical ventilation and 20.5 per 1000 ventilator days). The median day of VAE onset was day 7 of mechanical ventilation. The mean incidence of VAE (20.5 episodes per 1000 ventilator days) was 4.6 times higher compared to the standard population. By VAE subcategory, the highest mean incidence (10.50 per 1000 ventilator days) was observed in VACs, followed by IVACs and pVAPs with mean incidences of 6.44 and 3.57 per 1000 ventilator days respectively. The highest VAE rate per 100 episodes of mechanical ventilation was observed in VAC (17.50 per 100 episodes of mechanical ventilation), followed by IVAC and pVAP with rates of 10.76 and 5.96 per 100 episodes of mechanical ventilation respectively. The mean incidence of VAEs and the VAE rates varied by ICU and ranged from 16.79 to 22.73 per 1000 ventilator days and from 13.79 to 41.80 per 100 episodes of mechanical ventilation respectively. The highest mean incidence of VAEs and the highest VAE rates were observed in ICU 3 (22.16 per 1000 ventilator days and 41.80 per 100 episodes of mechanical ventilation respectively) and ICU 2 (22.12 per 1000 ventilator days and 39.23 per 100 episodes of mechanical ventilation respectively).The mean incidences of VAE subcategories varied by ICU, with the mean incidence of VACs ranging from 6.72 to 12.46 per 1000 ventilator days and the mean incidence of IVACs ranging from 4.71 to 8.10 per 1000 ventilator days respectively. The highest mean incidence of VAC and IVAC was observed in ICU 2 (12.46 and 8.10 per 1000 ventilator days respectively) and ICU 3 (11.26 and 6.95 per 1000 ventilator days respectively). Similarly, the highest rate of VAC and IVAC per 100 episodes of mechanical ventilation was observed in ICU 2 (22.10 and 14.36 per 100 episodes of mechanical ventilation respectively) and ICU 3 (21.31 and 13.11 per 100 episodes of mechanical ventilation respectively).In addition, the mean pVAP incidence varied by ICU and ranged from 1.56 to 5.00 per 1000 ventilator days. The highest mean incidence of pVAP was observed in ICU 1 (5.00 per 1000 ventilator days) and ICU 4 (4.20 per 1000 ventilator days), whereas the highest pVAP rate per 100 episodes of mechanical ventilation was observed in ICU 1 (7.94 per 100 episodes of mechanical ventilation) and in ICU 3 (7.38 per 100 episodes of mechanical ventilation). The Standardized Infection Ratio for all VAEs (VAE SIR) varied by ICU and ranged from 2.380 to 3.201. The highest VAE SIR was observed in ICU 3 and ICU 2 (3.201 and 2.746 respectively) and the highest IVAC plus SIR was observed in ICU 3 and ICU 4 (3.898 and 3.614 respectively).The Standardized Utilization Ratio (SUR) varied by ICU and ranged from 1.983 to 2.191. The highest SUR was observed in ICU 3 and ICU 4 (2.121 and 2.101 respectively). The Standardized Infection Ratio for all VAEs (VAE SIR) and for IVAC plus (IVAC plus SIR), as well as the SUR in each ICU were >1 and particularly high, reflecting the increased number of observed VAEs and observed IVAC plus in comparison to the expected ones, as well as the increased number of observed ventilator days compared to expected ventilator days. VAE SIR and SUR should be taken into account as they help to avoid biased comparisons and in addition, allow measurement of progress from a single point in time. The Device Utilization Ratio (DUR) by ICU ranged from 0.772 to 0.828, meaning that 77%-82% of patient days were ventilator days. The highest DUR was observed in ICU 3 and ICU 4 (0.828 and 0.817 respectively). The mean incidence of VAEs and the DUR (ventilator utilization rate) should be considered together, so that appropriate and targeted preventive measures are implemented. The differences in the surveillance measures by ICU that are mentioned above, could be attributed to the lack of a well-organized VAE surveillance system, the lack of a VAE control program, as well as to the differences between the diagnostic techniques and therapeutic interventions applied by the ICU clinical staff. The overall mortality in patients with VAE was 46.9%. Among the VAE tiers, the highest crude mortality (50.8%) was observed in IVAC, followed by VAC (47.2%) and pVAP (38.4%). Studying VAE burden after matching, showed that patients with VAE, VAC and IVAC had significantly worse outcomes than their matched “controls”. Specifically:- The median duration of mechanical ventilation in patients with VAE was significantly longer than in their matched “controls” (22 vs. 10 days, p<0.001). Similarly for VAC patients compared to their matched “controls” (22 vs. 10 days, p<0.001) and in IVAC plus patients compared to their matched “controls” (22.50 vs. 10 days, p=0.001).- The median length of ICU stay in patients with VAE was significantly longer compared to their matched “controls” (28 vs. 15 days, p<0.001), as well as in patients with VAC compared to their matched “controls” (29 vs. 15 days, p<0.001) and in IVAC patients compared to their matched “controls” (28 vs. 15 days, p<0.001).- Mortality among patients with VAE was significantly higher compared to themortality in their matched “controls” (46% vs. 21.5%, p<0.001). Similarly, mortality was significantly higher in VAC and IVAC patients than in their matched “controls” (45.9% vs. 22.4%, p<0.001) and (46.2% vs. 20.5%, p= 0.001) respectively. When investigating risk factors for VAEs, the following results emerged from multivariable conditional logistic regression:- positive mean daily fluid balance (OR=11.71, 95%CI=4.25-32.30,p<0.001)- mandatory modes of mechanical ventilation (OR=3.26, 95%CI=1.46-7.29, p=0.004)- red blood cells transfusion (OR=5.36, 95%CI=1.73-16.59 p=0.004)- sedation with propofol (OR=4.01, 95%CI=1.51-10.64, p=0.005) and- exposure to paralytics (OR=3.62, 95%CI=1.30-10.06, p=0.014)were associated with the occurrence of VAEs. From the results above, the following can be concluded: the implementation of protocols for conservative fluid management, tighter limits for red blood cells transfusion, avoidance of mandatory modes of mechanical ventilation, avoidance of sedation with propofol and avoidance of patients’ exposure to paralytics, (when patients’ condition allows) may contribute to the reduction of VAEs. When investigating risk factors for VAC, the following results emerged from the multivariable conditional logistic regression:- positive mean daily fluid balance (OR=10.61, 95%CI=3.34-33.72,p<0.001),- red blood cells transfusion (OR=12.32, 95%CI=2.08-72.94 p=0.006)and- enteral feeding through a nasogastric tube (OR=3.40, 95%CI=1.31-8.85,p=0.012)were associated with the occurrence of VAC. Therefore, from the results above, it is concluded that conservative fluid management based on protocols, tighter limits for red blood cell transfusions, and increased vigilance and monitoring of enterally fed patients via nasogastric tube (such as elevating the head of the bed, checking for presence of vomiting), may help in reducing VACs. When investigating risk factors for IVAC plus, the following results emerged from the multivariable conditional logistic regression:- positive mean daily fluid balance (OR=26.70, 95%CI=3.79-188.27,p<0.001),- red blood cells transfusion (OR=7.42, 95%CI=1.74-31.69, p=0,007) and- non-interrupted sedation (OR=5.50, 95%CI=1.59-19.42, p=0.008)were associated with the occurrence of IVAC plus. Therefore, from the results above, it is concluded that conservative management of administered fluids according to protocols, tighter limits for red blood cell transfusion and intermittent sedation, may contribute to the reduction of IVAC plus. From the investigation of risk factors for VAEs using Cox proportional hazard models, the following results emerged:- positive mean daily fluid balance (HR=4.57, 95%CI=2.84-7.34, p<0.001),- mandatory modes of mechanical ventilation (HR=1.93, 95%CI=1.42-2.63,p<0.001), - non-interrupted sedation (HR=1.74, 95%CI=1.29-2.35, p<0.001),- enteral feeding through a nasogastric tube (HR=1.45, 95%CI=1.05-2.01,p=0,025) and- chest tube placement (HR=2.08, 95%CI=1.38-3.15, p=0,001)were associated with the occurrence of VAEs. From the investigation of risk factors for VACs using Cox proportional hazard models, the following results emerged:- positive mean daily fluid balance (HR=5.17, 95%CI=1.72-15.52, p=0.003),- mandatory modes of mechanical ventilation (HR=2.81, 95%CI=1.52-5.17,p<0.001),- non-interrupted sedation (HR=2.19, 95%CI=1.24-3.89, p=0.007) and- chest tube placement (HR=1.13, 95%CI=1.07-1.19, p<0.001)were associated with the occurrence of VACs. From the investigation of risk factors for IVAC plus using Cox proportional hazard models, the following results emerged:- positive mean daily fluid balance (HR=4.58, 95%CI=2.41-8.72, p<0,001)- mandatory modes of mechanical ventilation (HR=2.25, 95%CI=1.42-3.57,p=0.001)- non-interrupted sedation (HR=2.43, 95%CI=1.58-3.72, p<0.001) and- patient exposure to paralytics (HR=1.95, 95%CI=1.14-3.32, p=0.014)were positively associated with the occurrence of IVAC plus, whereas a negative association with tracheostomy (HR=0.39, 95%CI=0.22-0.68,p=0.001) was found. From the Cox proportional hazard models, two new risk factors emerged. Specifically, uninterrupted sedation was a risk factor for VAE, VAC and IVAC plus and chest tube placement was a risk factor for VAE and VAC. These results indicate the importance of implementing protocols to minimize sedation in patients under invasive mechanical ventilation, as well as increased vigilance in patients with chest drains. As a final conclusion, this study is the first in the international literature to apply and analyze all VAE surveillance measures according to the CDC's National Healthcare Safety Network (NHSN), which are useful tools for decision-making and targeted feedback as well as staff training, so as to reduce the incidence of VAEs and improve the quality of patient care in the ICU. The fact that all the surveillance measures were high, highlighted the serious problem of VAEs in the ICUs. In addition, the appropriate methodology and statistical analysis of the data confirmed a significant number of modifiable risk factors of VAEs already identified in the international literature, while identifying two new potentially modifiable risk factors. Uninterrupted sedation and chest tube placement, were positively associated with the occurrence of VAEs and these observations are mentioned for the first time in the literature. This topic needs further research. However, randomized clinical trials are needed to clarify the picture of VAE risk factors.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Andreou, Evmorfia
  • Ανδρέου, Ευμορφία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54332

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Andreou, Evmorfia; Ανδρέου, Ευμορφία. Επίπτωση και παράγοντες κινδύνου των συμβαμάτων που σχετίζονται με τον αναπνευστήρα σε ασθενείς με μηχανική υποστήριξη αναπνοής στη ΜΕΘ. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/54332